HashiCorp (HCP) 10-Q 7 Dec 23 2024 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Oct. 31, 2023	Dec. 01, 2023
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 31, 2023
Document Transition Report	false
Entity File Number	001-41121
Entity Registrant Name	HashiCorp, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	32-0410665
Entity Address, Address Line One	101 Second Street
Entity Address, Address Line Two	Suite 700
Entity Address, City or Town	San Francisco
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94105
City Area Code	(415)
Local Phone Number	301-3250
Title of 12(b) Security	Class A Common Stock, par value $0.000015 per share
Trading Symbol	HCP
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001720671
Document Fiscal Period Focus	Q3
Amendment Flag	false
Current Fiscal Year End Date	--01-31
Document Fiscal Year Focus	2024
Common Class A
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		117,341,034
Common Class B
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		78,523,167

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Current assets:
Cash and cash equivalents	$ 729,826	$ 1,286,134
Short-term investments	525,825	0
Accounts receivable, net of allowance	108,183	162,369
Deferred contract acquisition costs	45,508	42,812
Prepaid expenses and other current assets	29,248	17,683
Total current assets	1,438,590	1,508,998
Deferred contract acquisition costs, non-current	79,676	81,286
Acquisition-related intangible assets, net	12,319	0
Goodwill	12,265	0
Other assets, non-current	43,419	38,056
Total assets	1,586,269	1,628,340
Current liabilities:
Accounts payable	6,111	12,450
Accrued expenses and other current liabilities	13,210	10,163
Accrued compensation and benefits	51,974	58,628
Deferred revenue	264,422	272,909
Customer deposits	22,173	26,699
Total current liabilities	357,890	380,849
Deferred revenue, non-current	25,780	29,335
Other liabilities, non-current	10,876	12,806
Total liabilities	394,546	422,990
Commitments and contingencies (Note 11)
Stockholders’ equity:
Additional paid-in capital	2,132,382	1,985,747
Accumulated other comprehensive loss	(1,216)	0
Accumulated deficit	(939,446)	(780,400)
Total stockholders’ equity	1,191,723	1,205,350
Total liabilities and stockholders’ equity	1,586,269	1,628,340
Common Class A
Stockholders’ equity:
Common stock	1	1
Common Class B
Stockholders’ equity:
Common stock	$ 2	$ 2

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Oct. 31, 2023	Jan. 31, 2023
Class A Common Stock
Common stock, par value (in dollars per share)	$ 0.000015	$ 0.000015
Common stock, shares authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, shares issued (in shares)	115,432,000	88,823,000
Common stock, shares outstanding (in shares)	115,432,000	88,823,000
Class B Common Stock
Common stock, par value (in dollars per share)	$ 0.000015	$ 0.000015
Common stock, shares authorized (in shares)	200,000,000	200,000,000
Common stock, shares issued (in shares)	80,096,000	101,145,000
Common stock, shares outstanding (in shares)	80,096,000	101,145,000

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Revenue:
Total revenue	$ 146,125	$ 125,341	$ 427,354	$ 340,101
Cost of revenue:
Total cost of revenue	25,605	22,548	81,727	63,477
Gross profit	120,520	102,793	345,627	276,624
Operating expenses:
Sales and marketing	87,320	92,872	279,019	260,798
Research and development	54,349	53,887	168,504	148,947
General and administrative	34,424	33,372	104,083	101,278
Total operating expenses	176,093	180,131	551,606	511,023
Loss from operations	(55,573)	(77,338)	(205,979)	(234,399)
Interest income	16,765	8,584	48,045	13,126
Other expense, net	(407)	(2,882)	(632)	(2,922)
Loss before income taxes	(39,215)	(71,636)	(158,566)	(224,195)
Provision for income taxes	258	322	480	744
Net loss	$ (39,473)	$ (71,958)	$ (159,046)	$ (224,939)
Net loss per share attributable to Class A and Class B common stockholders, basic (in dollars per share)	$ (0.20)	$ (0.38)	$ (0.83)	$ (1.22)
Net loss per share attributable to Class A and Class B common stockholders, diluted (in dollars per share)	$ (0.20)	$ (0.38)	$ (0.83)	$ (1.22)
Weighted-average shares used to compute net loss per share attributable to Class A and Class B common stockholders, basic (in shares)	194,600	187,080	192,693	185,124
Weighted-average shares used to compute net loss per share attributable to Class A and Class B common stockholders, diluted (in shares)	194,600	187,080	192,693	185,124
Subscription revenue
Revenue:
Total revenue	$ 141,934	$ 120,198	$ 414,642	$ 328,814
Cost of revenue:
Total cost of revenue	21,341	18,391	68,218	52,783
Subscription revenue | License
Revenue:
Total revenue	15,973	17,823	47,855	43,505
Cost of revenue:
Total cost of revenue	293	393	1,376	1,146
Subscription revenue | Support
Revenue:
Total revenue	106,098	89,500	312,008	252,965
Cost of revenue:
Total cost of revenue	13,356	12,149	44,503	35,259
Subscription revenue | Cloud-hosted services
Revenue:
Total revenue	19,863	12,875	54,779	32,344
Cost of revenue:
Total cost of revenue	7,692	5,849	22,339	16,378
Professional services and other
Revenue:
Total revenue	4,191	5,143	12,712	11,287
Cost of revenue:
Total cost of revenue	$ 4,264	$ 4,157	$ 13,509	$ 10,694

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Statement of Comprehensive Income [Abstract]
Net loss	$ (39,473)	$ (71,958)	$ (159,046)	$ (224,939)
Available-for-sale investments:
Unrealized gains (losses) on available-for-sale investments	38	0	(895)	0
Foreign currency forward contracts:
Unrealized losses on foreign currency forward contracts	(226)	0	(321)	0
Other comprehensive loss, net of tax	(188)	0	(1,216)	0
Total comprehensive loss	$ (39,661)	$ (71,958)	$ (160,262)	$ (224,939)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Class A and Class B Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2022		182,167
Beginning balance at Jan. 31, 2022	$ 1,282,291	$ 3	$ 1,788,390		$ (506,102)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		839
Issuance of common stock upon exercise of stock options	521		521
Vesting of early exercised stock options	3		3
Issuance of common stock upon settlement of restricted stock units (in shares)		710
Tax withholdings on settlement of restricted stock units (in shares)		(8)
Tax withholdings on settlement of restricted stock units	(125)		(125)
Stock-based compensation	47,141		47,141
Net loss	(78,217)				(78,217)
Ending balance (in shares) at Apr. 30, 2022		183,708
Ending balance at Apr. 30, 2022	1,251,614	$ 3	1,835,930		(584,319)
Beginning balance (in shares) at Jan. 31, 2022		182,167
Beginning balance at Jan. 31, 2022	1,282,291	$ 3	1,788,390		(506,102)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive loss	0
Net loss	(224,939)
Ending balance (in shares) at Oct. 31, 2022		187,841
Ending balance at Oct. 31, 2022	1,207,206	$ 3	1,938,244		(731,041)
Beginning balance (in shares) at Apr. 30, 2022		183,708
Beginning balance at Apr. 30, 2022	1,251,614	$ 3	1,835,930		(584,319)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		786
Issuance of common stock upon exercise of stock options	1,645		1,645
Vesting of early exercised stock options	2		2
Issuance of common stock upon settlement of restricted stock units (in shares)		1,477
Tax withholdings on settlement of restricted stock units (in shares)		(2)
Tax withholdings on settlement of restricted stock units	(77)		(77)
Issuance of common stock under employee stock purchase plan (in shares)		351
Issuance of common stock under employee stock purchase plan	8,501		8,501
Stock-based compensation	43,309		43,309
Net loss	(74,764)				(74,764)
Ending balance (in shares) at Jul. 31, 2022		186,320
Ending balance at Jul. 31, 2022	1,230,230	$ 3	1,889,310		(659,083)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		491
Issuance of common stock upon exercise of stock options	989		989
Vesting of early exercised stock options	1		1
Issuance of common stock upon settlement of restricted stock units (in shares)		1,032
Tax withholdings on settlement of restricted stock units (in shares)		(2)
Tax withholdings on settlement of restricted stock units	(20)		(20)
Stock-based compensation	47,964		47,964
Other comprehensive loss	0
Net loss	(71,958)				(71,958)
Ending balance (in shares) at Oct. 31, 2022		187,841
Ending balance at Oct. 31, 2022	1,207,206	$ 3	1,938,244		(731,041)
Beginning balance (in shares) at Jan. 31, 2023		189,968
Beginning balance at Jan. 31, 2023	1,205,350	$ 3	1,985,747	$ 0	(780,400)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		513
Issuance of common stock upon exercise of stock options	1,013		1,013
Issuance of common stock upon settlement of restricted stock units (in shares)		1,071
Tax withholdings on settlement of restricted stock units	(9)		(9)
Stock-based compensation	41,266		41,266
Other comprehensive loss	(66)			(66)
Net loss	(53,258)				(53,258)
Ending balance (in shares) at Apr. 30, 2023		191,552
Ending balance at Apr. 30, 2023	1,194,296	$ 3	2,028,017	(66)	(833,658)
Beginning balance (in shares) at Jan. 31, 2023		189,968
Beginning balance at Jan. 31, 2023	1,205,350	$ 3	1,985,747	0	(780,400)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive loss	(1,216)
Net loss	(159,046)
Ending balance (in shares) at Oct. 31, 2023		195,528
Ending balance at Oct. 31, 2023	1,191,723	$ 3	2,132,382	(1,216)	(939,446)
Beginning balance (in shares) at Apr. 30, 2023		191,552
Beginning balance at Apr. 30, 2023	1,194,296	$ 3	2,028,017	(66)	(833,658)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		366
Issuance of common stock upon exercise of stock options	442		442
Issuance of common stock upon settlement of restricted stock units (in shares)		1,307
Tax withholdings on settlement of restricted stock units (in shares)		(5)
Tax withholdings on settlement of restricted stock units	(215)		(215)
Issuance of common stock under employee stock purchase plan (in shares)		426
Issuance of common stock under employee stock purchase plan	10,195		10,195
Stock-based compensation	47,471		47,471
Other comprehensive loss	(962)			(962)
Net loss	(66,315)				(66,315)
Ending balance (in shares) at Jul. 31, 2023		193,646
Ending balance at Jul. 31, 2023	1,184,912	$ 3	2,085,910	(1,028)	(899,973)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		407
Issuance of common stock upon exercise of stock options	1,488		1,488
Issuance of common stock upon settlement of restricted stock units (in shares)		1,477
Tax withholdings on settlement of restricted stock units (in shares)		(2)
Tax withholdings on settlement of restricted stock units	(12)		(12)
Stock-based compensation	44,996		44,996
Other comprehensive loss	(188)			(188)
Net loss	(39,473)				(39,473)
Ending balance (in shares) at Oct. 31, 2023		195,528
Ending balance at Oct. 31, 2023	$ 1,191,723	$ 3	$ 2,132,382	$ (1,216)	$ (939,446)

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022
Cash flows from operating activities
Net loss	$ (159,046)	$ (224,939)
Adjustments to reconcile net loss to cash from operating activities:
Stock-based compensation expense, net of amounts capitalized	130,048	135,372
Depreciation and amortization expense	6,586	3,178
Non-cash operating lease cost	2,222	2,135
Accretion of discounts on marketable securities	(8,505)	0
Deferred income taxes	(482)	0
Other	67	(8)
Changes in operating assets and liabilities:
Accounts receivable	54,116	11,541
Deferred contract acquisition costs	(1,086)	(21,491)
Prepaid expenses and other assets	(11,843)	3,391
Accounts payable	(6,589)	2,100
Accrued expenses and other liabilities	(3,403)	(2,663)
Accrued compensation and benefits	(6,654)	(3,735)
Deferred revenue	(12,042)	10,893
Customer deposits	(4,526)	(1,814)
Net cash used in operating activities	(21,137)	(86,040)
Cash flows from investing activities
Business combination, net of cash acquired	(20,860)	0
Purchases of property and equipment	(491)	(140)
Capitalized internal-use software	(8,536)	(6,174)
Purchases of short-term investments	(691,220)	0
Proceeds from sales of short-term investments	26,372	0
Proceeds from maturities of short-term investments	146,662	0
Net cash used in investing activities	(548,073)	(6,314)
Cash flows from financing activities
Taxes paid related to net share settlement of equity awards	(236)	(222)
Proceeds from issuance of common stock upon exercise of stock options	2,943	3,155
Proceeds from issuance of common stock under employee stock purchase plan	10,195	8,501
Net cash provided by financing activities	12,902	11,434
Net decrease in cash, cash equivalents, and restricted cash	(556,308)	(80,920)
Cash, cash equivalents, and restricted cash beginning of period	1,286,134	1,357,613
Cash, cash equivalents, and restricted cash end of period	729,826	1,276,693
Supplemental disclosure of cash flow information
Cash paid for income taxes, net of refunds received	1,406	1,090
Cash paid for operating lease liabilities	2,912	2,827
Supplemental disclosure of noncash investing and financing activities
Capitalized stock-based compensation expense	3,685	3,042
Acquisition holdback	$ 4,100	$ 0

Organization and Description of

Organization and Description of Business	9 Months Ended
	Oct. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	1. Organization and Description of Business Description of Business

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Oct. 31, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies Basis of Presentation The accompanying condensed consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America ("U.S. GAAP" or "GAAP") and include the accounts of the Company and its wholly owned subsidiaries. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to the applicable rules and regulations of the Securities and Exchange Commission (the "SEC"). The condensed balance sheet data as of January 31, 2023 was derived from the Company’s audited financial statements included in its Annual Report on Form 10-K for the fiscal year ended January 31, 2023 (the fiscal “2023 Form 10-K”), but does not include all disclosures required by U.S. GAAP. Therefore, these interim condensed consolidated financial statements and accom panying footnotes should be read in conjunction with the Company’s annual consolidated financial statements and related footnotes included in the fiscal 2023 Form 10-K. The accompanying condensed consolidated financial statements reflect all adjustments, consisting only of normal recurring adjustments, that are, in the opinion of management, necessary for the fair presentation of the Company’s financial position, results of operations, cash flows, and stockholders’ equity for the interim periods presented. The results of operations for the three and nine months ended October 31, 2023 shown in this report are not necessarily indicative of the results to be expected for the full year ending January 31, 2024 or any other period. Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Use of Estimates The preparation of condensed consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of income and expense during the reporting period. Such management estimates include, but are not limited to, the determination of standalone selling prices of the Company’s performance obligations, the estimated period of benefit of deferred contract acquisition costs, the fair value of share-based awards, software development costs, discount rates used for operating leases, goodwill and acquisition-related intangible assets, and the valuation allowance on deferred tax assets and uncertain tax positions. These estimates are based on information available as of the date of the condensed consolidated financial statements; therefore, actual results could differ from those estimates. Accumulated Other Comprehensive Gain (Loss) As of October 31, 2023, accumulated other comprehensive loss was comprised of unrealized gain (losses) from available-for-sale investments and unrealized losses related to the effective portion of changes in the fair value of foreign currency forward contracts designated as cash flow hedges. Impairment of Long-Lived Assets Long-lived assets, such as property and equipment, acquired intangible assets, and capitalized software development costs subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. If circumstances require a long-lived asset be tested for possible impairment, the Company first compares undiscounted cash flows expected to be generated by the asset to its carrying value. If the carrying value of the long-lived asset is not recoverable on an undiscounted cash flow basis, an impairment is recognized to the extent that the carrying value exceeds its fair value. Fair value is determined through various valuation techniques, including discounted cash flow models, quoted market values, and third-party independent appraisals, as considered necessary. For the fiscal years presented, there were no impairment losses recognized for any long-lived assets. Significant Accounting Policies Other than the business combinations, goodwill, short-term investments and derivative instruments and hedging policies described below, there have been no changes to the Company’s significant accounting policies described in the fiscal 2023 Form 10-K that have had a material impact on these condensed consolidated financial statements and related notes. Business Combinations The Company recognizes identifiable assets acquired and liabilities assumed at their acquisition date fair value. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While the Company uses its best estimates and assumptions as a part of the purchase price allocation process to accurately value assets acquired and liabilities assumed at the acquisition date, its estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, the Company records adjustments to the assets acquired and liabilities assumed, with the corresponding offset to goodwill to the extent that the Company identifies adjustments to the preliminary purchase price allocation. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the Company’s consolidated statements of operations. There has been no such adjustment as of October 31, 2023. Goodwill Goodwill represents the excess of the purchase price of an acquired business over the fair value of the underlying net tangible and intangible assets. Goodwill is evaluated for impairment annually in the fourth quarter of the Company’s fiscal year, and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Triggering events that may indicate impairment include, but are not limited to, a significant adverse change in customer demand or business climate that could affect the value of goodwill, or a significant decrease in expected cash flows. As of October 31, 2023, the Company has not had any goodwill impairments. Short-term Investments The Company’s short-term investments consist of U.S. treasury securities, corporate notes and bonds, U.S. agency obligations, commercial paper, and certificates of deposit. The Company determines the appropriate classification of its short-term investments at the time of purchase and reevaluates such determination at each balance sheet date. The Company has classified and accounted for its short-term investments as available-for-sale securities. The Company may sell these securities at any time for use in its current operations or for other purposes, even prior to maturity. As a result, the Company classifies its short-term investments, including those with maturities beyond twelve months, as current assets in the consolidated balance sheets. Available-for-sale securities are recorded at fair value each reporting period, and are adjusted for amortization of premiums and accretion of discounts to maturity and such amortization and accretion are included in interest income in the condensed consolidated statements of operations. Realized gains and losses are determined based on the specific identification method and are reported in other expense, net in the condensed consolidated statements of operations. Unrealized gains are reported as a separate component of accumulated other comprehensive loss on the condensed consolidated balance sheets until realized. For available-for-sale securities in an unrealized loss position, the Company first assesses whether it intends to sell the security or it is more likely than not that the Company will be required to sell the security before the recovery of its entire amortized cost basis. If either of these criteria is met, the security’s amortized cost basis is written down to fair value through other expense, net in the condensed consolidated statements of operations. If neither of these criteria is met, the Company evaluates whether the decline in fair value below amortized cost is due to credit or non-credit related factors. In making this assessment, the Company considers the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and any adverse conditions specifically related to the security, among other factors. Credit related unrealized losses are recognized as an allowance for expected credit losses of available-for-sale debt securities on the condensed consolidated balance sheets with a corresponding charge in other expense, net, net in the condensed consolidated statements of operations. Non-credit related unrealized losses are included in accumulated other comprehensive loss. As of October 31, 2023, the Company did not identify any credit losses on short-term investments. Realized gains and losses on the sale of short-term investments are determined on a specific identification method and are recorded in other expense, net in the consolidated statements of operations. For the three and nine months ended October 31, 2023, the realized gains or losses on the sale of short-term investments were not material. Derivative Instruments and Hedging The Company enters into foreign currency forward contracts with certain financial institutions to mitigate the impact of foreign currency fluctuations on future cash flows and earnings. All of the Company’s foreign currency forward contracts are designated as cash flow hedges. The foreign currency forward contracts generally have maturities of 12 months or less. The Company recognizes all forward contracts as either assets or liabilities on the consolidated balance sheets at fair value. Gains and losses on each forward contract are initially reported as a component of accumulated other comprehensive income (loss) (“AOCI”), and subsequently reclassified into cost of revenue or operating expense in the same period, or periods, during which the hedged transaction affects earnings. The Company evaluates the effectiveness of its cash flow hedges on a quarterly basis and does not exclude any component of the changes in fair value of the derivative instruments for effectiveness testing purposes. The Company classifies cash flows related to its cash flow hedges as operating activities in its consolidated statements of cash flows. The Company does not have collateral requirements with any of its counterparties. The Company does not use derivative instruments for trading or speculative purposes.

Business Combinations

Business Combinations	9 Months Ended
	Oct. 31, 2023
Business Combination and Asset Acquisition [Abstract]
Business Combinations	3. Business Combinations On June 2, 2023 (the "Closing"), the Company acquired all outstanding share capital of BluBracket, Inc. (“BluBracket acquisition”). BluBracket was a Palo Alto-based security startup that developed a code security solution that identifies, prevents, and resolves potential risks in source code, development environments, and pipelines. The Company expects that the BluBracket technology will enable our customers to have full visibility into their entire secrets inventory, complementing our Vault product offering. The aggregate purchase price was $25.1 million settled in cash (the "Purchase Price") of which the Company held back approximately $4.0 million for 14 months after the Closing and $0.2 million within one year following the Closing to satisfy indemnification obligations of BluBracket (the "Holdback"). As of October 31, 2023, $0.1 million of the remaining Holdback has been paid, $3.6 million is accrued as a current liability, and $0.5 million is accrued as a non-current liability in the condensed consolidated balance sheet. The purchase price excludes retention agreements entered into with certain employees of BluBracket, pursuant to which the Company will pay up to an aggregate of $5.0 million in cash (the “Retention Payments”). The vesting and payout of the Retention Payments is subject to continued employment and achievement of certain semi-annual milestones over two years following the Closing. The Retention Payment is recorded as post-combination compensation expense within research and development in the condensed consolidated statements of operations over the requisite service period. During the three and nine months ended October 31, 2023, the Company recognized compensation expense of $0.6 million and $1.0 million, respectively, related to the Retention Payment agreements. The acquisition was accounted for as a business combination. A portion of the Purchase Price was allocated to the fair value of the developed technology and customer relationship acquired, net liabilities assumed and a deferred tax liability related to developed technology, as set forth below. The useful lives for these acquired developed technology and the customer relationship were estimated to be five The following table presents the purchase price allocation related to the acquisition (in thousands): Net liabilities $ (224) Developed technology 12,500 Customer relationship 1,000 Deferred tax liabilities (482) Goodwill 12,265 Total purchase consideration $ 25,059 The estimated fair value of developed technology and customer relationship acquired of $12.5 million and $1.0 million were determined using a replacement cost approach methodology, which is based on the cost that a market participant would incur to reconstruct a substitute asset of comparable utility and generate the acquired portfolio of customers, respectively. There were no measurement period adjustments during the reporting period ended October 31, 2023. The financial results of BluBracket are included in the Company's consolidated financial statements from the date of acquisition. The business combination did not have a material impact on the consolidated financial statements and therefore historical and pro forma disclosures have not been presented.

Goodwill and Acquisition-relate

Goodwill and Acquisition-related Intangible Assets, Net	9 Months Ended
	Oct. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Acquisition-related Intangible Assets, Net	4. Goodwill and Acquisition-related Intangible Assets, Net Goodwill Goodwill as of October 31, 2023 was $12.3 million. No goodwill was recorded as of January 31, 2023. During the nine months ended October 31, 2023, changes in goodwill consisted of the following (in thousands): Balance as of January 31, 2023 $ — BluBracket, Inc. (Note 3) 12,265 Balance as of October 31, 2023 $ 12,265 Acquisition-related Intangible Assets, Net Acquisition-related intangible assets, net consisted of the following as of October 31, 2023 (in thousands except for useful life): Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Remaining Useful Life Developed technology $ 12,500 $ 1,042 $ 11,458 4.6 Customer relationship $ 1,000 $ 139 $ 861 2.6 Acquired intangible assets are recorded at cost, net of accumulated amortization, and are amortized on a straight-line basis over their estimated useful lives. Amortization expense of acquired developed technology was included in cost of cloud-hosted services in the condensed consolidated statements of operations and was $0.6 million and $1.0 million for the three and nine months ended October 31, 2023, respectively. Amortization expense of customer relationship was included in sales and marketing in the condensed consolidated statements of operations, and was not significant for the three and nine months ended October 31, 2023. Estimated future amortization expense as of October 31, 2023 is as follows (in thousands): Year ending January 31, Amount 2024 (remaining three months) $ 708 2025 2,833 2026 2,833 2027 2,612 2028 2,500 2029 and thereafter 833 Total $ 12,319

Revenue and Performance Obligat

Revenue and Performance Obligations	9 Months Ended
	Oct. 31, 2023
Disaggregation of Revenue [Abstract]
Revenue and Performance Obligations	5. Revenue and Performance Obligations Disaggregation of revenue The following table presents revenue by category (in thousands, except percentages): Three Months Ended October 31, Nine Months Ended October 31, 2023 2022 2023 2022 Amount % of Total Amount % of Total Amount % of Total Amount % of Total License $ 15,973 11 % $ 17,823 14 % $ 47,855 11 % $ 43,505 13 % Support 106,098 72 89,500 72 312,008 73 252,965 74 Cloud-hosted services 19,863 14 12,875 10 54,779 13 32,344 10 Total subscription revenue 141,934 97 120,198 96 414,642 97 328,814 97 Professional services and other 4,191 3 5,143 4 12,712 3 11,287 3 Total revenue $ 146,125 100 % $ 125,341 100 % $ 427,354 100 % $ 340,101 100 % The following table summarizes the revenue by region based on the billing address of customers who have contracted to use the Company's products and services (in thousands, except percentages): Three Months Ended October 31, Nine Months Ended October 31, 2023 2022 2023 2022 Amount % of Total Amount % of Total Amount % of Total Amount % of Total United States $ 102,365 70 % $ 91,503 73 % $ 300,979 70 % $ 247,695 73 % Rest of the world 43,760 30 33,838 27 126,375 30 92,406 27 Total $ 146,125 100 % $ 125,341 100 % $ 427,354 100 % $ 340,101 100 % No other country, outside of the United States, exceeded 10% of total revenue during the periods presented. Contract Balances Changes in deferred revenue and unbilled accounts receivable were as follows (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2023 2022 2023 2022 Balance, beginning of period $ 293,441 $ 226,812 $ 302,244 $ 223,289 Deferred revenue billings including reclassification to deferred revenue from customer deposits 142,390 131,351 415,646 350,879 Recognition of revenue, net of change in unbilled accounts receivable* (145,629) (123,981) (427,688) (339,986) Balance, end of period $ 290,202 $ 234,182 $ 290,202 $ 234,182 * Reconciliation to revenue reported per consolidated statements of operations: Revenue billed as of the end of the period $ 145,629 $ 123,981 $ 427,688 $ 339,986 Increase (decrease) in total unbilled accounts receivable 496 1,360 (334) 115 Revenue reported per consolidated statements of operations $ 146,125 $ 125,341 $ 427,354 $ 340,101 Unbilled accounts receivable represents revenue recognized on contracts for which billings have not yet been presented to customers because the amounts were earned but not contractually billable as of the balance sheet date. The unbilled accounts receivable balance is due within one year. As of October 31, 2023 and January 31, 2023, unbilled accounts receivable of approximately $4.6 million and $4.9 million, respectively, were included in accounts receivable on the Company’s condensed consolidated balance sheets. Remaining Performance Obligations (RPOs) The typical stated customer contract term is one year but can range up to three years. RPOs include both deferred revenue and non-cancelable contracted amounts that will be invoiced and recognized as revenue in future periods. As of October 31, 2023 and January 31, 2023, the Company had $678.2 million and $647.1 million, respectively, of remaining performance obligations, which is comprised of product and services revenue not yet delivered. As of October 31, 2023 and January 31, 2023, the Company expected to recognize approximately 59% and 58%, respectively, of its remaining performance obligations as revenue over the next 12 months and the remainder thereafter. RPOs exclude customer deposits, which are refundable pre-paid amounts that are expected to be recognized as revenue in future periods. These balances are included in customer deposits in the condensed consolidated balance sheets and are classified as current because contractually customers can cancel these obligations with 30 days written notice. The customer deposit balance is amortized to revenue over the term of the underlying contract as the customer’s right to cancel expires. If no contracts with customers are cancelled, the existing customer deposit balance will be recognized to revenue over the remaining stated term of the underlying contract which may be over the next 12 months or longer as follows (in thousands): As of October 31, 2023 January 31, 2023 Within the next 12 months $ 18,728 $ 22,657 After the next 12 months 3,445 4,042 Total $ 22,173 $ 26,699

Short-term Investments

Short-term Investments	9 Months Ended
	Oct. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Short-term Investments	6. Short-term Investments The following tables summarize the fair values of the Company’s short-term investments (in thousands): As of October 31, 2023 Amortized Cost Unrealized Gains Unrealized Losses Fair Value U.S. treasury securities $ 277,357 $ 6 $ (404) $ 276,959 U.S. agency obligations 73,465 — (146) 73,319 Corporate notes and bonds 100,611 4 (355) 100,260 Commercial paper 43,758 — — 43,758 Certificates of deposit 31,529 — — 31,529 Total short-term investments $ 526,720 $ 10 $ (905) $ 525,825 The Company does not hold any marketable securities that have been in a continuous unrealized loss position for over 12 months. For short-term investments with an unrealized loss at October 31, 2023, the unrealized losses were not due to credit-related factors, the Company does not intend to sell these short-term investments and it is more likely than not that the Company will hold these short-term investments until maturity or a recovery of the cost basis. Therefore no allowance for expected credit losses was recorded as of October 31, 2023. Realized gains (losses) were not material for the three and nine months ended October 31, 2023. The following table summarizes the contractual maturities of the Company’s short-term investments (in thousands): As of October 31, 2023 Amortized Cost Fair Value Due within one year $ 473,940 $ 473,254 Due after one year through three years 52,780 52,571 Total $ 526,720 $ 525,825

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Oct. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	7. Fair Value Measurements The following table sets forth the financial assets, measured at fair value, by level within the fair value hierarchy on a recurring basis and indicates the fair value hierarchy of the valuation inputs used to determine such fair value (in thousands): Fair Value Measurement As of October 31, 2023 Fair Value Level Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Assets: Cash and cash equivalents: Money market funds Level 1 13,221 — — 13,221 U.S. treasury securities Level 2 19,847 — — 19,847 Corporate notes and bonds Level 2 995 — — 995 Commercial paper Level 2 9,675 — — 9,675 Total assets measured at fair value included in cash and cash equivalents $ 43,738 $ — $ — $ 43,738 Short-term Investments: U.S. treasury securities Level 2 $ 277,357 6 (404) $ 276,959 U.S. agency obligations Level 2 73,465 — (146) 73,319 Corporate notes and bonds Level 2 100,611 4 (355) 100,260 Commercial paper Level 2 43,758 — — 43,758 Certificates of deposit Level 2 31,529 — — 31,529 Total short-term investments $ 526,720 $ 10 $ (905) $ 525,825 Total assets measured at fair value $ 570,458 $ 10 $ (905) $ 569,563 Liabilities: Derivative instruments: Foreign currency forward contracts Level 2 $ — $ — $ 321 $ 321 Total derivative instruments — — 321 321 Total liabilities measured at fair value $ — $ — $ 321 $ 321 The following table summarizes the respective fair value and the classification by level within the fair value hierarchy (in thousands): Fair Value Measurement As of January 31, 2023 Fair Value Level Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Assets: Cash and cash equivalents: Money market funds Level 1 $ 169,904 $ — $ — $ 169,904 Total cash and cash equivalents 169,904 — — 169,904 Total assets measured at fair value $ 169,904 $ — $ — $ 169,904 The Company classifies its highly liquid money market funds within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. The Company classifies its corporate notes and bonds, U.S. treasury securities, U.S. agency obligations, commercial paper, certificate of deposits and foreign currency forward contracts within Level 2 of the fair value hierarchy because they are valued using inputs other than quoted prices that are directly or indirectly observable in the market, including readily available pricing sources for the identical underlying security that may not be actively traded. As of October 31, 2023, the declines in the market value of the Company's short-term investment portfolio were not driven by credit related factors. As of October 31, 2023, the Company determined that it does not intend to sell any securities with a decline in market value, and it is more likely than not that the Company will be able to hold these securities until the entire principal has been recovered. Therefore, the Company did not recognize any losses on short-term investments due to credit related factors. As of October 31, 2023, the total unrealized losses on short-term investments were $0.9 million. There were no transfers between fair value measurement levels during the nine months ended October 31, 2023.

Derivative Instruments and Hedg

Derivative Instruments and Hedging	9 Months Ended
	Oct. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments and Hedging	8. Derivative Instruments and Hedging In June 2023, the Company began entering into foreign currency forward contracts to manage its exposure to certain foreign currency exchange risks. The Company’s derivative instruments generally have maturities of 12 months or less. The Company does not use derivative instruments for trading or speculative purposes. As of October 31, 2023, the Company’s foreign currency forward contracts had an aggregate notional amount of $6.0 million. The Company does not have collateral requirements with any of its counterparties. The following table summarizes the fair value of the Company’s derivative instruments on the condensed consolidated balance sheets (in thousands): Balance Sheet Location Fair Value Derivative Liabilities: Foreign currency forward contracts designated as hedging instruments Accrued expenses and other liabilities $ 321 Total derivative liabilities $ 321 The following table presents the activity of foreign currency forward contracts designated as hedging instruments and the impact of these derivatives on AOCI (in thousands): Nine Months Ended October 31, Beginning balance $ — Net gains (losses) recognized in other comprehensive income (483) Net (gains) losses reclassified from AOCI to earnings 162 Ending balance $ (321) As of October 31, 2023, net unrealized loss included in the balance of accumulated other comprehensive loss related to foreign currency forward contracts designated as hedging instruments was $0.3 million, all of which the Company expects to reclassify from accumulated other comprehensive loss into earnings over the next 12 months. The effect of foreign currency forward contracts were not material to the condensed consolidated financials for the three and nine months ended October 31, 2023.

Balance Sheet Components

Balance Sheet Components	9 Months Ended
	Oct. 31, 2023
Supplemental Balance Sheet Disclosures [Abstract]
Balance Sheet Components	9. Balance Sheet Components Other Assets, Non-Current Other assets, non-current are comprised of the following (in thousands): As of October 31, 2023 January 31, 2023 Property and equipment, net $ 31,973 $ 24,594 Operating lease right-of-use assets 10,338 12,560 Other 1,108 902 Total other assets, non-current $ 43,419 $ 38,056 Property and Equipment, Net Property and equipment, net are included in other assets, non-current in the condensed consolidated balance sheets and are comprised of the following (in thousands): Estimated As of October 31, 2023 January 31, 2023 Furniture and fixtures 5 years $ 1,329 $ 1,292 Computers, equipment and software 3 years 580 581 Capitalized internal-use software development costs 5 years 38,038 25,817 Leasehold improvements Shorter of useful life or lease term 5,563 5,138 Construction in progress 76 47 Total property and equipment 45,586 32,875 Less: accumulated depreciation and amortization (13,613) (8,281) Property and equipment, net $ 31,973 $ 24,594 Total depreciation and amortization expense for property and equipment for the three months ended October 31, 2023 and 2022 was $2.0 million and $1.2 million, respectively. Total depreciation and amortization expense for property and equipment for the nine months ended October 31, 2023 and 2022 was $5.4 million and $3.1 million, respectively. The Company capitalized $4.1 million and $3.9 million in internal-use software development costs for the three months ended October 31, 2023 and 2022, and $12.2 million and $9.2 million for the nine months ended October 31, 2023 and 2022, respectively. Amortization expense associated with internal-use software development costs totaled $1.7 million and $0.9 million for three months ended October 31, 2023 and 2022, respectively, and $4.5 million and $2.3 million for the nine months ended October 31, 2023 and 2022. Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities are comprised of the following (in thousands): As of October 31, 2023 January 31, 2023 Operating lease liabilities $ 3,683 $ 3,380 Acquisition holdback, current 3,554 — Accrued expenses 3,262 4,222 Sales tax payable 1,470 1,480 Accrued income taxes payable 920 1,081 Derivative liabilities 321 — Total accrued expenses and other current liabilities $ 13,210 $ 10,163 Accrued Compensation and Benefits Accrued compensation and benefits are comprised of the following (in thousands): As of October 31, 2023 January 31, 2023 Accrued commissions $ 10,113 $ 16,932 Accrued vacation 22,078 20,614 Accrued payroll and withholding taxes 5,679 11,574 ESPP employee contributions 7,992 4,247 Accrued bonus 3,342 3,220 Other 2,769 2,041 Total accrued compensation and benefits $ 51,974 $ 58,628 Deferred Contract Acquisition Costs The following table summarizes the activity of deferred contract acquisition costs (in thousands): Nine Months Ended October 31, 2023 2022 Beginning balance $ 124,098 $ 89,331 Capitalization of contract acquisition costs 41,272 53,002 Amortization of deferred contract acquisition costs (40,186) (31,511) Ending balance $ 125,184 $ 110,822 Deferred contract acquisition costs, current $ 45,508 $ 37,317 Deferred contract acquisition costs, non-current 79,676 73,505 Total deferred contract acquisition costs $ 125,184 $ 110,822 There were no impairment losses recognized for deferred contract acquisition costs during the three and nine months ended October 31, 2023 and 2022. Other Liabilities, Non-Current The following table summarizes the activity of other liabilities, non-current (in thousands): As of October 31, 2023 January 31, 2023 Operating lease liabilities, non-current $ 9,301 $ 12,093 Acquisition holdback, non-current 546 — Accrued commissions, non-current 1,029 713 Total other liabilities, non-current $ 10,876 $ 12,806

Leases

Leases	9 Months Ended
	Oct. 31, 2023
Leases [Abstract]
Leases	10. Leases The Company leases office spaces under noncancelable operating lease agreements, which expire at various dates through 2028. The Company is required to pay property taxes, insurance, and normal maintenance costs for certain of these facilities. Operating lease cost for these leases is recognized on a straight-line basis over the lease term, with variable lease costs recognized in the period incurred. These lease agreements do not contain residual value guarantees or restrictive covenants. Lease costs Lease costs were as follows (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2023 2022 2023 2022 Short-term lease costs $ 174 $ 39 $ 514 $ 184 Operating lease costs 878 878 2,634 2,634 Total lease costs $ 1,052 $ 917 $ 3,148 $ 2,818 Variable lease cost was not significant for the three and nine months ended October 31, 2023 and 2022. There were no other lease components for the periods presented. Lease term and discount rate information are summarized as follows: As of October 31, 2023 Weighted average remaining lease terms (in years) 3.4 Weighted average discount rate 3.8 % Future lease payments under noncancelable operating leases on an undiscounted cash flow basis as of October 31, 2023 are as follows (in thousands): Years Ending January 31, Amount 2024 (remaining three months) $ 1,012 2025 4,150 2026 3,734 2027 3,737 2028 1,277 Total minimum lease payments 13,910 Less imputed interest (926) Present value of future minimum lease payments 12,984 Less current lease liabilities (3,683) Operating lease liabilities, non-current $ 9,301 Operating lease liabilities are included in accrued expenses and other current liabilities, and non-current lease liabilities are included in other liabilities, non-current, in the condensed consolidated balance sheets. There were no lease related operating right-of-use asset impairment losses in the three and nine months ended October 31, 2023 and 2022.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Oct. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	11. Commitments and Contingencies Letter of credit The Company has a total of $1.8 million in letters of credit outstanding as security deposits for the Company’s leased office spaces as of October 31, 2023 and January 31, 2023. Litigation From time to time, the Company may become involved in various legal proceedings in the ordinary course of its business and may be subject to third-party infringement claims. In the normal course of business, the Company may agree to indemnify third parties with whom it enters into contractual relationships, including customers, lessors, and parties to other transactions with the Company, with respect to certain matters. The Company has agreed, under certain conditions, to hold these third parties harmless against specified losses, such as those arising from a breach of representations or covenants, other third-party claims that the Company’s products when used for their intended purposes infringe the intellectual property rights of such other third parties, or other claims made against certain parties. It is not possible to determine the maximum potential amount of liability under these indemnification obligations due to the Company’s limited history of prior indemnification claims and the unique facts and circumstances that are likely to be involved in each particular claim.

Common Stock and Stockholders'

Common Stock and Stockholders' Equity	9 Months Ended
	Oct. 31, 2023
Equity [Abstract]
Common Stock and Stockholders' Equity	12. Common Stock and Stockholders' Equity Common Stock Reserved for Future Issuance The Company reserved shares of common stock for future issuance as follows (in thousands): As of October 31, 2023 January 31, 2023 Options outstanding 8,011 9,315 Restricted stock units outstanding 13,491 11,588 Remaining shares available for future issuance under the 2021 Equity Incentive Plan ("2021 Plan") 25,231 21,466 2021 Employee Stock Purchase Plan ("ESPP") 4,481 3,008 Total 51,214 45,377 Stock Options The following table summarizes stock option activity for the 2021 Plan (shares and aggregate intrinsic value in thousands): Options Outstanding Number of Options Outstanding Weighted- Average Exercise Price Weighted- Average Remaining Contractual Aggregate Intrinsic Value Balance as of January 31, 2023 9,315 $ 1.92 4.6 $ 281,837 Stock options exercised (1,286) 2.29 33,922 Stock options cancelled/forfeited/expired (18) 22.39 Balance as of October 31, 2023 8,011 1.82 3.8 143,570 Exercisable as of October 31, 2023 7,984 $ 1.75 3.8 $ 143,442 The total grant-date fair value of stock options vested was $1.0 million and $3.8 million during the nine months ended October 31, 2023 and 2022. The total intrinsic value of options exercised during the nine months ended October 31, 2023 and 2022 were $33.9 million and $74.1 million, respectively. Restricted Stock Units The Company’s summary of restricted stock units ("RSUs") activity under the 2021 Plan is as follows (in thousands): Number of Awards Weighted-Average Grant Date Fair Value Outstanding and unvested at January 31, 2023 11,588 $ 42.48 RSUs granted 7,679 $ 28.92 RSUs released (3,855) $ 34.77 RSUs cancelled (1,921) $ 37.53 Outstanding and unvested at October 31, 2023 13,491 $ 37.66 The total grant-date fair value of RSUs vested was $134.0 million and $105.1 million during the nine months ended October 31, 2023 and 2022. Employee Stock Purchase Plan A total of 4,480,939 shares of Class A common stock are available for future issuance under the ESPP as of October 31, 2023. For the nine months ended October 31, 2023 and 2022, the Company recognized $9.6 million and $9.1 million of stock-based compensation expense related to the ESPP, respectively. As of October 31, 2023, unrecognized stock-based compensation expense related to the ESPP was approximately $12.2 million, which is expected to be recognized over a weighted-average period of approximately 1.1 years. ESPP employee payroll contributions accrued as of October 31, 2023 were $8.0 million and are reported within accrued compensation and benefits in the consolidated balance sheets. Payroll contributions accrued as of October 31, 2023 will be used to purchase shares at the end of the current purchase period ending on December 15, 2023. Payroll contributions ultimately used to purchase shares will be reclassified as stockholders’ equity on the purchase date. Stock-Based Compensation Expense Total stock-based compensation expense recognized in the Company’s condensed consolidated statements of operations is as follows (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2023 2022 2023 2022 Cost of support $ 2,411 $ 2,152 $ 7,511 $ 6,332 Cost of cloud-hosted services 601 792 1,767 2,118 Cost of professional services and other 734 722 1,947 2,102 Sales and marketing 13,923 15,398 41,365 44,212 Research and development 12,674 14,988 37,347 40,233 General and administrative 13,423 12,658 40,111 40,375 Stock-based compensation expense, net of amounts capitalized $ 43,766 $ 46,710 $ 130,048 $ 135,372 Capitalized stock-based compensation 1,230 1,254 3,685 3,042 Total stock-based compensation expense $ 44,996 $ 47,964 $ 133,733 $ 138,414 As of October 31, 2023 and 2022, total unrecognized stock-based compensation expense related to RSUs was approximately $376.4 million and $389.1 million, respectively, which are expected to be recognized over a weighted-average period of approximately 2.9 years and 2.9 years, respectively. As of October 31, 2023, and 2022, total unrecognized stock-based compensation expense related to unvested stock options was approximately $0.3 million and $2.1 million, respectively, which are expected to be recognized over a weighted-average period of approximately 1.0 year and 1.3 years, respectively.

Net Loss Per Share Attributable

Net Loss Per Share Attributable to Common Stockholders	9 Months Ended
	Oct. 31, 2023
Earnings Per Share [Abstract]
Net Loss Per Share Attributable to Common Stockholders	13. Net Loss Per Share Attributable to Common Stockholders For periods in which there were Class A and Class B shares outstanding, the rights, including the liquidation and dividend rights, of the holders of Class A and Class B common stock were identical, except with respect to voting, converting, and transfer rights. Class B common stock has ten votes per share, and Class A common stock has one vote per share. As the liquidation and dividend rights were identical for Class A and Class B common stock, the undistributed earnings would be allocated on a proportionate basis and the resulting net loss per share would, therefore, be the same for both Class A and Class B common stock on an individual or combined basis. The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data): Three Months Ended October 31, Nine Months Ended October 31, 2023 2022 2023 2022 Numerator: Net loss $ (39,473) $ (71,958) $ (159,046) $ (224,939) Denominator: Weighted-average shares used to compute net loss per share attributable to Class A and Class B common stockholders, basic and diluted 194,600 187,080 192,693 185,124 Net loss per share attributable to Class A and Class B common stockholders, basic and diluted $ (0.20) $ (0.38) $ (0.83) $ (1.22) The following outstanding potentially dilutive shares of common stock were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because the impact of including them would have been antidilutive (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2023 2022 2023 2022 Outstanding stock options and restricted stock units 21,502 22,233 21,502 22,233 Share purchase rights under the ESPP 1,205 1,491 1,077 1,239 Total 22,707 23,724 22,579 23,472

Reduction in Workforce and Rela

Reduction in Workforce and Related Charges	9 Months Ended
	Oct. 31, 2023
Restructuring and Related Activities [Abstract]
Reduction in Workforce and Related Charges	14. Reduction In Workforce and Related Charges On June 7, 2023, the Company announced a workforce reduction plan impacting approximately 8% of the Company’s workforce. The workforce reduction plan was intended to increase operational efficiency, decrease costs and increase profitability. As of October 31, 2023, the Company has substantially completed the reduction plan.

Income Taxes

Income Taxes	9 Months Ended
	Oct. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	15. Income Taxes The Company determines its income tax provision for interim periods using an estimate of its annual effective tax rate adjusted for discrete items occurring during the periods presented. The primary difference between the effective tax rate and the federal statutory rate is related to nonrecognition of tax benefits due to valuation allowance established for US federal and state deferred tax assets. The Company recorded income tax expenses of $0.5 million and $0.7 million for the nine months ended October 31, 2023 and 2022, respectively. The tax expense for the nine months ended October 31, 2023 included a partial release of valuation allowance, of which $0.5 million tax benefit was directly related to the acquisition of BluBracket, Inc. In connection with the BluBracket acquisition, the Company recorded a net deferred tax liability which provides an additional source of taxable income to support the realization of the pre-existing deferred tax assets and, accordingly, during the nine months ended October 31, 2023, the Company released a total of $0.5 million of its U.S. valuation allowance. The Company continues to maintain a valuation allowance for its U.S. Federal and state net deferred tax assets. The tax expense for the nine months ended October 31, 2023 was primarily due to foreign and US state income tax expense. The Company is subject to income tax in the United States, certain states, and various foreign countries. Due to the history of net operating losses, the Company is subject to United States federal, state, and local examinations by tax authorities for all years since incorporation.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Oct. 31, 2023	Jul. 31, 2023	Apr. 30, 2023	Oct. 31, 2022	Jul. 31, 2022	Apr. 30, 2022	Oct. 31, 2023	Oct. 31, 2022
Pay vs Performance Disclosure
Net loss	$ (39,473)	$ (66,315)	$ (53,258)	$ (71,958)	$ (74,764)	$ (78,217)	$ (159,046)	$ (224,939)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	9 Months Ended
	Oct. 31, 2023 shares	Oct. 31, 2023 shares
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Navam Welihinda [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement
Armon Dadgar [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		On September 7, 2023, Armon Dadgar, our Co-Founder, Chief Technology Officer and Director, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The plan provides for the sale of an aggregate of up to 1,029,830 shares of our common stock by Mr. Dadgar and his affiliated entities, the Armon Dadgar 2020 Charitable Trust and Black Swan III LLC. The actual amount sold will be less based on tax withholdings. The plan will terminate on December 31, 2024, subject to early termination for certain specified events set forth in the plan.
Name	Armon Dadgar
Title	Co-Founder, Chief Technology Officer and Director
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	September 7, 2023
Arrangement Duration	481 days
Aggregate Available	1,029,830	1,029,830

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Oct. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying condensed consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America ("U.S. GAAP" or "GAAP") and include the accounts of the Company and its wholly owned subsidiaries. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to the applicable rules and regulations of the Securities and Exchange Commission (the "SEC"). The condensed balance sheet data as of January 31, 2023 was derived from the Company’s audited financial statements included in its Annual Report on Form 10-K for the fiscal year ended January 31, 2023 (the fiscal “2023 Form 10-K”), but does not include all disclosures required by U.S. GAAP. Therefore, these interim condensed consolidated financial statements and accom panying footnotes should be read in conjunction with the Company’s annual consolidated financial statements and related footnotes included in the fiscal 2023 Form 10-K. The accompanying condensed consolidated financial statements reflect all adjustments, consisting only of normal recurring adjustments, that are, in the opinion of management, necessary for the fair presentation of the Company’s financial position, results of operations, cash flows, and stockholders’ equity for the interim periods presented. The results of operations for the three and nine months ended October 31, 2023 shown in this report are not necessarily indicative of the results to be expected for the full year ending January 31, 2024 or any other period.
Principles of Consolidation	Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of income and expense during the reporting period. Such management estimates include, but are not limited to, the determination of standalone selling prices of the Company’s performance obligations, the estimated period of benefit of deferred contract acquisition costs, the fair value of share-based awards, software development costs, discount rates used for operating leases, goodwill and acquisition-related intangible assets, and the valuation allowance on deferred tax assets and uncertain tax positions. These estimates are based on information available as of the date of the condensed consolidated financial statements; therefore, actual results could differ from those estimates.
Accumulated Other Comprehensive Gain (Loss)	Accumulated Other Comprehensive Gain (Loss) As of October 31, 2023, accumulated other comprehensive loss was comprised of unrealized gain (losses) from available-for-sale investments and unrealized losses related to the effective portion of changes in the fair value of foreign currency forward contracts designated as cash flow hedges.
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets
Significant Accounting Policies	Significant Accounting Policies Other than the business combinations, goodwill, short-term investments and derivative instruments and hedging policies described below, there have been no changes to the Company’s significant accounting policies described in the fiscal 2023 Form 10-K that have had a material impact on these condensed consolidated financial statements and related notes.
Business Combinations	Business Combinations The Company recognizes identifiable assets acquired and liabilities assumed at their acquisition date fair value. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While the Company uses its best estimates and assumptions as a part of the purchase price allocation process to accurately value assets acquired and liabilities assumed at the acquisition date, its estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, the Company records adjustments to the assets acquired and liabilities assumed, with the corresponding offset to goodwill to the extent that the Company identifies adjustments to the preliminary purchase price allocation. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the Company’s consolidated statements of operations. There has been no such adjustment as of October 31, 2023.
Goodwill	Goodwill Goodwill represents the excess of the purchase price of an acquired business over the fair value of the underlying net tangible and intangible assets. Goodwill is evaluated for impairment annually in the fourth quarter of the Company’s fiscal year, and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Triggering events that may indicate impairment include, but are not limited to, a significant adverse change in customer demand or business climate that could affect the value of goodwill, or a significant decrease in expected cash flows.
Short-term Investments	Short-term Investments The Company’s short-term investments consist of U.S. treasury securities, corporate notes and bonds, U.S. agency obligations, commercial paper, and certificates of deposit. The Company determines the appropriate classification of its short-term investments at the time of purchase and reevaluates such determination at each balance sheet date. The Company has classified and accounted for its short-term investments as available-for-sale securities. The Company may sell these securities at any time for use in its current operations or for other purposes, even prior to maturity. As a result, the Company classifies its short-term investments, including those with maturities beyond twelve months, as current assets in the consolidated balance sheets. Available-for-sale securities are recorded at fair value each reporting period, and are adjusted for amortization of premiums and accretion of discounts to maturity and such amortization and accretion are included in interest income in the condensed consolidated statements of operations. Realized gains and losses are determined based on the specific identification method and are reported in other expense, net in the condensed consolidated statements of operations. Unrealized gains are reported as a separate component of accumulated other comprehensive loss on the condensed consolidated balance sheets until realized. For available-for-sale securities in an unrealized loss position, the Company first assesses whether it intends to sell the security or it is more likely than not that the Company will be required to sell the security before the recovery of its entire amortized cost basis. If either of these criteria is met, the security’s amortized cost basis is written down to fair value through other expense, net in the condensed consolidated statements of operations. If neither of these criteria is met, the Company evaluates whether the decline in fair value below amortized cost is due to credit or non-credit related factors. In making this assessment, the Company considers the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and any adverse conditions specifically related to the security, among other factors. Credit related unrealized losses are recognized as an allowance for expected credit losses of available-for-sale debt securities on the condensed consolidated balance sheets with a corresponding charge in other expense, net, net in the condensed consolidated statements of operations. Non-credit related unrealized losses are included in accumulated other comprehensive loss.
Derivative Instruments and Hedging	Derivative Instruments and Hedging The Company enters into foreign currency forward contracts with certain financial institutions to mitigate the impact of foreign currency fluctuations on future cash flows and earnings. All of the Company’s foreign currency forward contracts are designated as cash flow hedges. The foreign currency forward contracts generally have maturities of 12 months or less. The Company recognizes all forward contracts as either assets or liabilities on the consolidated balance sheets at fair value. Gains and losses on each forward contract are initially reported as a component of accumulated other comprehensive income (loss) (“AOCI”), and subsequently reclassified into cost of revenue or operating expense in the same period, or periods, during which the hedged transaction affects earnings. The Company evaluates the effectiveness of its cash flow hedges on a quarterly basis and does not exclude any component of the changes in fair value of the derivative instruments for effectiveness testing purposes. The Company classifies cash flows related to its cash flow hedges as operating activities in its consolidated statements of cash flows. The Company does not have collateral requirements with any of its counterparties. The Company does not use derivative instruments for trading or speculative purposes.

Business Combinations (Tables)

Business Combinations (Tables)	9 Months Ended
	Oct. 31, 2023
Business Combination and Asset Acquisition [Abstract]
Summary of Purchase Price Allocation	The following table presents the purchase price allocation related to the acquisition (in thousands): Net liabilities $ (224) Developed technology 12,500 Customer relationship 1,000 Deferred tax liabilities (482) Goodwill 12,265 Total purchase consideration $ 25,059

Goodwill and Acquisition-rela_2

Goodwill and Acquisition-related Intangible Assets, Net (Tables)	9 Months Ended
	Oct. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	During the nine months ended October 31, 2023, changes in goodwill consisted of the following (in thousands): Balance as of January 31, 2023 $ — BluBracket, Inc. (Note 3) 12,265 Balance as of October 31, 2023 $ 12,265
Schedule of Finite-Lived Intangible Assets	Acquisition-related intangible assets, net consisted of the following as of October 31, 2023 (in thousands except for useful life): Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Remaining Useful Life Developed technology $ 12,500 $ 1,042 $ 11,458 4.6 Customer relationship $ 1,000 $ 139 $ 861 2.6
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	Estimated future amortization expense as of October 31, 2023 is as follows (in thousands): Year ending January 31, Amount 2024 (remaining three months) $ 708 2025 2,833 2026 2,833 2027 2,612 2028 2,500 2029 and thereafter 833 Total $ 12,319

Revenue and Performance Oblig_2

Revenue and Performance Obligations (Tables)	9 Months Ended
	Oct. 31, 2023
Disaggregation of Revenue [Abstract]
Summary of Revenue Disaggregated by Category	The following table presents revenue by category (in thousands, except percentages): Three Months Ended October 31, Nine Months Ended October 31, 2023 2022 2023 2022 Amount % of Total Amount % of Total Amount % of Total Amount % of Total License $ 15,973 11 % $ 17,823 14 % $ 47,855 11 % $ 43,505 13 % Support 106,098 72 89,500 72 312,008 73 252,965 74 Cloud-hosted services 19,863 14 12,875 10 54,779 13 32,344 10 Total subscription revenue 141,934 97 120,198 96 414,642 97 328,814 97 Professional services and other 4,191 3 5,143 4 12,712 3 11,287 3 Total revenue $ 146,125 100 % $ 125,341 100 % $ 427,354 100 % $ 340,101 100 %
Summary of Revenue by Region Based on the Billing Address of Customers	The following table summarizes the revenue by region based on the billing address of customers who have contracted to use the Company's products and services (in thousands, except percentages): Three Months Ended October 31, Nine Months Ended October 31, 2023 2022 2023 2022 Amount % of Total Amount % of Total Amount % of Total Amount % of Total United States $ 102,365 70 % $ 91,503 73 % $ 300,979 70 % $ 247,695 73 % Rest of the world 43,760 30 33,838 27 126,375 30 92,406 27 Total $ 146,125 100 % $ 125,341 100 % $ 427,354 100 % $ 340,101 100 %
Summary of Changes in Deferred Revenue and Unbilled Accounts Receivable	Changes in deferred revenue and unbilled accounts receivable were as follows (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2023 2022 2023 2022 Balance, beginning of period $ 293,441 $ 226,812 $ 302,244 $ 223,289 Deferred revenue billings including reclassification to deferred revenue from customer deposits 142,390 131,351 415,646 350,879 Recognition of revenue, net of change in unbilled accounts receivable* (145,629) (123,981) (427,688) (339,986) Balance, end of period $ 290,202 $ 234,182 $ 290,202 $ 234,182 * Reconciliation to revenue reported per consolidated statements of operations: Revenue billed as of the end of the period $ 145,629 $ 123,981 $ 427,688 $ 339,986 Increase (decrease) in total unbilled accounts receivable 496 1,360 (334) 115 Revenue reported per consolidated statements of operations $ 146,125 $ 125,341 $ 427,354 $ 340,101
Summary of Revenue Recognized Related to Customer Deposit Balance	If no contracts with customers are cancelled, the existing customer deposit balance will be recognized to revenue over the remaining stated term of the underlying contract which may be over the next 12 months or longer as follows (in thousands): As of October 31, 2023 January 31, 2023 Within the next 12 months $ 18,728 $ 22,657 After the next 12 months 3,445 4,042 Total $ 22,173 $ 26,699

Short-term Investments (Tables)

Short-term Investments (Tables)	9 Months Ended
	Oct. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Summary of Fair Value of Short-term Investments	The following tables summarize the fair values of the Company’s short-term investments (in thousands): As of October 31, 2023 Amortized Cost Unrealized Gains Unrealized Losses Fair Value U.S. treasury securities $ 277,357 $ 6 $ (404) $ 276,959 U.S. agency obligations 73,465 — (146) 73,319 Corporate notes and bonds 100,611 4 (355) 100,260 Commercial paper 43,758 — — 43,758 Certificates of deposit 31,529 — — 31,529 Total short-term investments $ 526,720 $ 10 $ (905) $ 525,825
Summary of Contractual Maturities	The following table summarizes the contractual maturities of the Company’s short-term investments (in thousands): As of October 31, 2023 Amortized Cost Fair Value Due within one year $ 473,940 $ 473,254 Due after one year through three years 52,780 52,571 Total $ 526,720 $ 525,825

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Oct. 31, 2023
Fair Value Disclosures [Abstract]
Schedule of Financial Assets Measured at Fair Value on a Recurring Basis	The following table sets forth the financial assets, measured at fair value, by level within the fair value hierarchy on a recurring basis and indicates the fair value hierarchy of the valuation inputs used to determine such fair value (in thousands): Fair Value Measurement As of October 31, 2023 Fair Value Level Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Assets: Cash and cash equivalents: Money market funds Level 1 13,221 — — 13,221 U.S. treasury securities Level 2 19,847 — — 19,847 Corporate notes and bonds Level 2 995 — — 995 Commercial paper Level 2 9,675 — — 9,675 Total assets measured at fair value included in cash and cash equivalents $ 43,738 $ — $ — $ 43,738 Short-term Investments: U.S. treasury securities Level 2 $ 277,357 6 (404) $ 276,959 U.S. agency obligations Level 2 73,465 — (146) 73,319 Corporate notes and bonds Level 2 100,611 4 (355) 100,260 Commercial paper Level 2 43,758 — — 43,758 Certificates of deposit Level 2 31,529 — — 31,529 Total short-term investments $ 526,720 $ 10 $ (905) $ 525,825 Total assets measured at fair value $ 570,458 $ 10 $ (905) $ 569,563 Liabilities: Derivative instruments: Foreign currency forward contracts Level 2 $ — $ — $ 321 $ 321 Total derivative instruments — — 321 321 Total liabilities measured at fair value $ — $ — $ 321 $ 321 The following table summarizes the respective fair value and the classification by level within the fair value hierarchy (in thousands): Fair Value Measurement As of January 31, 2023 Fair Value Level Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Assets: Cash and cash equivalents: Money market funds Level 1 $ 169,904 $ — $ — $ 169,904 Total cash and cash equivalents 169,904 — — 169,904 Total assets measured at fair value $ 169,904 $ — $ — $ 169,904

Derivative Instruments and He_2

Derivative Instruments and Hedging (Tables)	9 Months Ended
	Oct. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Summary of the Fair Value of Derivative Instruments	The following table summarizes the fair value of the Company’s derivative instruments on the condensed consolidated balance sheets (in thousands): Balance Sheet Location Fair Value Derivative Liabilities: Foreign currency forward contracts designated as hedging instruments Accrued expenses and other liabilities $ 321 Total derivative liabilities $ 321
Schedule of Derivatives and the Impact on AOCI	The following table presents the activity of foreign currency forward contracts designated as hedging instruments and the impact of these derivatives on AOCI (in thousands): Nine Months Ended October 31, Beginning balance $ — Net gains (losses) recognized in other comprehensive income (483) Net (gains) losses reclassified from AOCI to earnings 162 Ending balance $ (321)

Balance Sheet Components (Table

Balance Sheet Components (Tables)	9 Months Ended
	Oct. 31, 2023
Supplemental Balance Sheet Disclosures [Abstract]
Summary of Other Assets Non-current	Other assets, non-current are comprised of the following (in thousands): As of October 31, 2023 January 31, 2023 Property and equipment, net $ 31,973 $ 24,594 Operating lease right-of-use assets 10,338 12,560 Other 1,108 902 Total other assets, non-current $ 43,419 $ 38,056
Summary of Property and Equipment, Net	Property and equipment, net are included in other assets, non-current in the condensed consolidated balance sheets and are comprised of the following (in thousands): Estimated As of October 31, 2023 January 31, 2023 Furniture and fixtures 5 years $ 1,329 $ 1,292 Computers, equipment and software 3 years 580 581 Capitalized internal-use software development costs 5 years 38,038 25,817 Leasehold improvements Shorter of useful life or lease term 5,563 5,138 Construction in progress 76 47 Total property and equipment 45,586 32,875 Less: accumulated depreciation and amortization (13,613) (8,281) Property and equipment, net $ 31,973 $ 24,594
Summary of Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities are comprised of the following (in thousands): As of October 31, 2023 January 31, 2023 Operating lease liabilities $ 3,683 $ 3,380 Acquisition holdback, current 3,554 — Accrued expenses 3,262 4,222 Sales tax payable 1,470 1,480 Accrued income taxes payable 920 1,081 Derivative liabilities 321 — Total accrued expenses and other current liabilities $ 13,210 $ 10,163
Summary of Accrued Compensation and Benefits	Accrued compensation and benefits are comprised of the following (in thousands): As of October 31, 2023 January 31, 2023 Accrued commissions $ 10,113 $ 16,932 Accrued vacation 22,078 20,614 Accrued payroll and withholding taxes 5,679 11,574 ESPP employee contributions 7,992 4,247 Accrued bonus 3,342 3,220 Other 2,769 2,041 Total accrued compensation and benefits $ 51,974 $ 58,628
Summary of Activity of Deferred Contract Acquisition Costs	The following table summarizes the activity of deferred contract acquisition costs (in thousands): Nine Months Ended October 31, 2023 2022 Beginning balance $ 124,098 $ 89,331 Capitalization of contract acquisition costs 41,272 53,002 Amortization of deferred contract acquisition costs (40,186) (31,511) Ending balance $ 125,184 $ 110,822 Deferred contract acquisition costs, current $ 45,508 $ 37,317 Deferred contract acquisition costs, non-current 79,676 73,505 Total deferred contract acquisition costs $ 125,184 $ 110,822
Schedule of Other Liabilities, Non-current	The following table summarizes the activity of other liabilities, non-current (in thousands): As of October 31, 2023 January 31, 2023 Operating lease liabilities, non-current $ 9,301 $ 12,093 Acquisition holdback, non-current 546 — Accrued commissions, non-current 1,029 713 Total other liabilities, non-current $ 10,876 $ 12,806

Leases (Tables)

Leases (Tables)	9 Months Ended
	Oct. 31, 2023
Leases [Abstract]
Schedule of Lease Costs	Lease costs were as follows (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2023 2022 2023 2022 Short-term lease costs $ 174 $ 39 $ 514 $ 184 Operating lease costs 878 878 2,634 2,634 Total lease costs $ 1,052 $ 917 $ 3,148 $ 2,818
Summary of Lease Term and Discount Rate	Lease term and discount rate information are summarized as follows: As of October 31, 2023 Weighted average remaining lease terms (in years) 3.4 Weighted average discount rate 3.8 %
Schedule of Future Lease Payments	Future lease payments under noncancelable operating leases on an undiscounted cash flow basis as of October 31, 2023 are as follows (in thousands): Years Ending January 31, Amount 2024 (remaining three months) $ 1,012 2025 4,150 2026 3,734 2027 3,737 2028 1,277 Total minimum lease payments 13,910 Less imputed interest (926) Present value of future minimum lease payments 12,984 Less current lease liabilities (3,683) Operating lease liabilities, non-current $ 9,301

Common Stock and Stockholders_2

Common Stock and Stockholders' Equity (Tables)	9 Months Ended
	Oct. 31, 2023
Equity [Abstract]
Schedule of Reserved Shares of Common Stock for Future Issuance	The Company reserved shares of common stock for future issuance as follows (in thousands): As of October 31, 2023 January 31, 2023 Options outstanding 8,011 9,315 Restricted stock units outstanding 13,491 11,588 Remaining shares available for future issuance under the 2021 Equity Incentive Plan ("2021 Plan") 25,231 21,466 2021 Employee Stock Purchase Plan ("ESPP") 4,481 3,008 Total 51,214 45,377
Schedule of Stock Option Activity	The following table summarizes stock option activity for the 2021 Plan (shares and aggregate intrinsic value in thousands): Options Outstanding Number of Options Outstanding Weighted- Average Exercise Price Weighted- Average Remaining Contractual Aggregate Intrinsic Value Balance as of January 31, 2023 9,315 $ 1.92 4.6 $ 281,837 Stock options exercised (1,286) 2.29 33,922 Stock options cancelled/forfeited/expired (18) 22.39 Balance as of October 31, 2023 8,011 1.82 3.8 143,570 Exercisable as of October 31, 2023 7,984 $ 1.75 3.8 $ 143,442
Schedule of Restricted Stock Units (RSUs") Activity	The Company’s summary of restricted stock units ("RSUs") activity under the 2021 Plan is as follows (in thousands): Number of Awards Weighted-Average Grant Date Fair Value Outstanding and unvested at January 31, 2023 11,588 $ 42.48 RSUs granted 7,679 $ 28.92 RSUs released (3,855) $ 34.77 RSUs cancelled (1,921) $ 37.53 Outstanding and unvested at October 31, 2023 13,491 $ 37.66
Summary of Stock-Based Compensation Expense	Total stock-based compensation expense recognized in the Company’s condensed consolidated statements of operations is as follows (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2023 2022 2023 2022 Cost of support $ 2,411 $ 2,152 $ 7,511 $ 6,332 Cost of cloud-hosted services 601 792 1,767 2,118 Cost of professional services and other 734 722 1,947 2,102 Sales and marketing 13,923 15,398 41,365 44,212 Research and development 12,674 14,988 37,347 40,233 General and administrative 13,423 12,658 40,111 40,375 Stock-based compensation expense, net of amounts capitalized $ 43,766 $ 46,710 $ 130,048 $ 135,372 Capitalized stock-based compensation 1,230 1,254 3,685 3,042 Total stock-based compensation expense $ 44,996 $ 47,964 $ 133,733 $ 138,414

Net Loss Per Share Attributab_2

Net Loss Per Share Attributable to Common Stockholders (Tables)	9 Months Ended
	Oct. 31, 2023
Earnings Per Share [Abstract]
Summary of Computation of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders	The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data): Three Months Ended October 31, Nine Months Ended October 31, 2023 2022 2023 2022 Numerator: Net loss $ (39,473) $ (71,958) $ (159,046) $ (224,939) Denominator: Weighted-average shares used to compute net loss per share attributable to Class A and Class B common stockholders, basic and diluted 194,600 187,080 192,693 185,124 Net loss per share attributable to Class A and Class B common stockholders, basic and diluted $ (0.20) $ (0.38) $ (0.83) $ (1.22)
Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss Per Share	The following outstanding potentially dilutive shares of common stock were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because the impact of including them would have been antidilutive (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2023 2022 2023 2022 Outstanding stock options and restricted stock units 21,502 22,233 21,502 22,233 Share purchase rights under the ESPP 1,205 1,491 1,077 1,239 Total 22,707 23,724 22,579 23,472

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) $ in Thousands	Oct. 31, 2023 USD ($)
Accounting Policies [Abstract]
Goodwill impairment	$ 0

Business Combinations - Additio

Business Combinations - Additional Information (Details) - USD ($) $ in Thousands		3 Months Ended	5 Months Ended	9 Months Ended
	Jun. 02, 2023	Oct. 31, 2023	Oct. 31, 2023	Oct. 31, 2023	Jan. 31, 2023
Business Acquisition [Line Items]
Acquisition holdback, current		$ 3,554	$ 3,554	$ 3,554	$ 0
Acquisition holdback, non-current		546	546	$ 546	$ 0
Developed technology
Business Acquisition [Line Items]
Weighted average useful life				4 years 7 months 6 days
Customer relationship
Business Acquisition [Line Items]
Weighted average useful life				2 years 7 months 6 days
BluBracket
Business Acquisition [Line Items]
Purchase price	$ 25,100
Liabilities incurred	$ 4,000
Liabilities incurred, period	14 months
Liabilities incurred, due within one year	$ 200
Purchase price			100
Acquisition holdback, current		3,600	3,600	$ 3,600
Acquisition holdback, non-current		500	$ 500	500
Retention agreement, maximum payment	$ 5,000
Compensation expense		600		1,000
Acquisition related costs		$ 0		$ 500
BluBracket | Developed technology
Business Acquisition [Line Items]
Weighted average useful life	5 years
Intangible assets acquired	$ 12,500
BluBracket | Customer relationship
Business Acquisition [Line Items]
Weighted average useful life	3 years
Intangible assets acquired	$ 1,000

Business Combinations - Summary

Business Combinations - Summary of Business Combination (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jun. 02, 2023	Jan. 31, 2023
Business Acquisition [Line Items]
Goodwill	$ 12,265		$ 0
BluBracket
Business Acquisition [Line Items]
Net liabilities		$ (224)
Deferred tax liabilities		(482)
Goodwill		12,265
Total purchase consideration		25,059
Developed technology | BluBracket
Business Acquisition [Line Items]
Intangible assets acquired		12,500
Customer relationship | BluBracket
Business Acquisition [Line Items]
Intangible assets acquired		$ 1,000

Goodwill and Acquisition-rela_3

Goodwill and Acquisition-related Intangible Assets, Net - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Oct. 31, 2023	Oct. 31, 2023	Jun. 02, 2023	Jan. 31, 2023
Goodwill [Line Items]
Goodwill	$ 12,265	$ 12,265		$ 0
BluBracket
Goodwill [Line Items]
Goodwill			$ 12,265
BluBracket | Developed technology
Goodwill [Line Items]
Accumulated Amortization	$ 600	$ 1,000

Goodwill and Acquisition-rela_4

Goodwill and Acquisition-related Intangible Assets, Net - Schedule of Goodwill (Details) $ in Thousands	9 Months Ended
	Oct. 31, 2023 USD ($)
Goodwill [Roll Forward]
Balance as of January 31, 2023	$ 0
Bluebracket, Inc	12,265
Balance as of October 31, 2023	$ 12,265

Goodwill and Acquisition-rela_5

Goodwill and Acquisition-related Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets (Details) - USD ($) $ in Thousands		9 Months Ended
	Jun. 02, 2023	Oct. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Net Carrying Amount		$ 12,319
Developed technology
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount		12,500
Accumulated Amortization		1,042
Net Carrying Amount		$ 11,458
Weighted Average Remaining Useful Life (in years)		4 years 7 months 6 days
Customer relationship
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount		$ 1,000
Accumulated Amortization		139
Net Carrying Amount		$ 861
Weighted Average Remaining Useful Life (in years)		2 years 7 months 6 days
BluBracket | Developed technology
Finite-Lived Intangible Assets [Line Items]
Weighted Average Remaining Useful Life (in years)	5 years
BluBracket | Customer relationship
Finite-Lived Intangible Assets [Line Items]
Weighted Average Remaining Useful Life (in years)	3 years

Goodwill and Acquisition-rela_6

Goodwill and Acquisition-related Intangible Assets, Net - Schedule of Amortization Expense (Details) $ in Thousands	Oct. 31, 2023 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2024 (remaining three months)	$ 708
2025	2,833
2026	2,833
2027	2,612
2028	2,500
2029 and thereafter	833
Net Carrying Amount	$ 12,319

Revenue and Performance Oblig_3

Revenue and Performance Obligations - Summary of Revenue Disaggregated by Category (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Disaggregation Of Revenue [Line Items]
Amount	$ 146,125	$ 125,341	$ 427,354	$ 340,101
% of Total Revenue | Product
Disaggregation Of Revenue [Line Items]
% of Total Revenue	100%	100%	100%	100%
Subscription revenue
Disaggregation Of Revenue [Line Items]
Amount	$ 141,934	$ 120,198	$ 414,642	$ 328,814
Subscription revenue | % of Total Revenue | Product
Disaggregation Of Revenue [Line Items]
% of Total Revenue	97%	96%	97%	97%
Subscription revenue | License
Disaggregation Of Revenue [Line Items]
Amount	$ 15,973	$ 17,823	$ 47,855	$ 43,505
Subscription revenue | License | % of Total Revenue | Product
Disaggregation Of Revenue [Line Items]
% of Total Revenue	11%	14%	11%	13%
Subscription revenue | Support
Disaggregation Of Revenue [Line Items]
Amount	$ 106,098	$ 89,500	$ 312,008	$ 252,965
Subscription revenue | Support | % of Total Revenue | Product
Disaggregation Of Revenue [Line Items]
% of Total Revenue	72%	72%	73%	74%
Subscription revenue | Cloud-hosted services
Disaggregation Of Revenue [Line Items]
Amount	$ 19,863	$ 12,875	$ 54,779	$ 32,344
Subscription revenue | Cloud-hosted services | % of Total Revenue | Product
Disaggregation Of Revenue [Line Items]
% of Total Revenue	14%	10%	13%	10%
Professional services and other
Disaggregation Of Revenue [Line Items]
Amount	$ 4,191	$ 5,143	$ 12,712	$ 11,287
Professional services and other | % of Total Revenue | Product
Disaggregation Of Revenue [Line Items]
% of Total Revenue	3%	4%	3%	3%

Revenue and Performance Oblig_4

Revenue and Performance Obligations - Summary of Revenue by Region Based on the Billing Address of Customers (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Revenues From External Customers And Long Lived Assets [Line Items]
Amount	$ 146,125	$ 125,341	$ 427,354	$ 340,101
% of Total Revenue | Region
Revenues From External Customers And Long Lived Assets [Line Items]
% of Total Revenue	100%	100%	100%	100%
United States
Revenues From External Customers And Long Lived Assets [Line Items]
Amount	$ 102,365	$ 91,503	$ 300,979	$ 247,695
United States | % of Total Revenue | Region
Revenues From External Customers And Long Lived Assets [Line Items]
% of Total Revenue	70%	73%	70%	73%
Rest of the world
Revenues From External Customers And Long Lived Assets [Line Items]
Amount	$ 43,760	$ 33,838	$ 126,375	$ 92,406
Rest of the world | % of Total Revenue | Region
Revenues From External Customers And Long Lived Assets [Line Items]
% of Total Revenue	30%	27%	30%	27%

Revenue and Performance Oblig_5

Revenue and Performance Obligations - Changes in Deferred Revenue and Unbilled Accounts Receivable (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Contract With Customer, Change In Contract With Customer, Asset, And Liability [Roll Forward]
Balance, beginning of period	$ 293,441	$ 226,812	$ 302,244	$ 223,289
Deferred revenue billings including reclassification to deferred revenue from customer deposits	142,390	131,351	415,646	350,879
Recognition of revenue, net of change in unbilled accounts receivable	(145,629)	(123,981)	(427,688)	(339,986)
Balance, end of period	290,202	234,182	290,202	234,182
* Reconciliation to revenue reported per consolidated statements of operations:
Revenue billed as of the end of the period	145,629	123,981	427,688	339,986
Increase (decrease) in total unbilled accounts receivable	496	1,360	(334)	115
Revenue reported per consolidated statements of operations	$ 146,125	$ 125,341	$ 427,354	$ 340,101

Revenue and Performance Oblig_6

Revenue and Performance Obligations - Additional Information (Details) - USD ($) $ in Millions	9 Months Ended
	Oct. 31, 2023	Jan. 31, 2023
Disaggregation Of Revenue [Line Items]
Unbilled accounts receivable balance in due	1 year
Unbilled accounts receivable	$ 4.6	$ 4.9
Remaining performance obligations	$ 678.2	$ 647.1
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-02-01
Disaggregation Of Revenue [Line Items]
Remaining performance obligations, percentage		58%
Revenue remaining performance obligation, expected timing of satisfaction, period		12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-11-01
Disaggregation Of Revenue [Line Items]
Remaining performance obligations, percentage	59%
Revenue remaining performance obligation, expected timing of satisfaction, period	12 months
Minimum
Disaggregation Of Revenue [Line Items]
Revenue, performance obligation, contract term	1 year
Maximum
Disaggregation Of Revenue [Line Items]
Revenue, performance obligation, contract term	3 years

Revenue and Performance Oblig_7

Revenue and Performance Obligations - Summary of Revenue Recognized Related to Customer Deposit Balance (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Disaggregation of Revenue [Abstract]
Within the next 12 months	$ 18,728	$ 22,657
After the next 12 months	3,445	4,042
Total	$ 22,173	$ 26,699

Short-term Investments - Summar

Short-term Investments - Summary of Fair Value of Short-term Investments (Details) $ in Thousands	Oct. 31, 2023 USD ($)
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	$ 526,720
Gross Unrealized Gains	10
Gross Unrealized Losses	(905)
Estimated Fair Value	525,825
U.S. treasury securities
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	277,357
Gross Unrealized Gains	6
Gross Unrealized Losses	(404)
Estimated Fair Value	276,959
U.S. agency obligations
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	73,465
Gross Unrealized Gains	0
Gross Unrealized Losses	(146)
Estimated Fair Value	73,319
Corporate notes and bonds
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	100,611
Gross Unrealized Gains	4
Gross Unrealized Losses	(355)
Estimated Fair Value	100,260
Commercial paper
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	43,758
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Estimated Fair Value	43,758
Certificates of deposit
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	31,529
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Estimated Fair Value	$ 31,529

Short-term Investments - Additi

Short-term Investments - Additional Information (Details)	Oct. 31, 2023 USD ($)
Investments, Debt and Equity Securities [Abstract]
Allowance for expected credit losses	$ 0

Short-term Investments - Summ_2

Short-term Investments - Summary of Contractual Maturities (Details) $ in Thousands	Oct. 31, 2023 USD ($)
Amortized Cost
Due within one year	$ 473,940
Due after one year through three years	52,780
Amortized Cost	526,720
Fair Value
Due within one year	473,254
Due after one year through three years	52,571
Estimated Fair Value	$ 525,825

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Financial Assets Measured at Fair Value, by Level Within the Fair Value Hierarchy on a Recurring Basis (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Short-term Investments:
Amortized Cost	$ 526,720
Gross Unrealized Gains	10
Gross Unrealized Losses	(905)
Estimated Fair Value	525,825
U.S. treasury securities
Short-term Investments:
Amortized Cost	277,357
Gross Unrealized Gains	6
Gross Unrealized Losses	(404)
Estimated Fair Value	276,959
U.S. agency obligations
Short-term Investments:
Amortized Cost	73,465
Gross Unrealized Gains	0
Gross Unrealized Losses	(146)
Estimated Fair Value	73,319
Corporate notes and bonds
Short-term Investments:
Amortized Cost	100,611
Gross Unrealized Gains	4
Gross Unrealized Losses	(355)
Estimated Fair Value	100,260
Commercial paper
Short-term Investments:
Amortized Cost	43,758
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Estimated Fair Value	43,758
Certificates of deposit
Short-term Investments:
Amortized Cost	31,529
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Estimated Fair Value	31,529
Fair Value, Recurring
Cash and cash equivalents:
Amortized Cost	43,738	$ 169,904
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Estimated Fair Value	43,738	169,904
Short-term Investments:
Amortized Cost	526,720
Gross Unrealized Gains	10
Gross Unrealized Losses	(905)
Estimated Fair Value	525,825
Total asset measured at fair value, amortized cost	570,458	169,904
Total assets measured at fair value, gross unrealized gains	10	0
Total asset measured at fair value, gross unrealized losses	(905)	0
Total Assets	569,563	169,904
Derivative instruments:
Derivative instruments	321
Level 1 | Fair Value, Recurring | Money market funds
Cash and cash equivalents:
Amortized Cost	13,221	169,904
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Estimated Fair Value	13,221	$ 169,904
Level 2 | Fair Value, Recurring
Derivative instruments:
Derivative instruments	321
Level 2 | Fair Value, Recurring | Foreign currency forward contracts
Derivative instruments:
Derivative instruments	321
Level 2 | Fair Value, Recurring | U.S. treasury securities
Cash and cash equivalents:
Amortized Cost	19,847
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Estimated Fair Value	19,847
Level 2 | Fair Value, Recurring | Corporate notes and bonds
Cash and cash equivalents:
Amortized Cost	995
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Estimated Fair Value	995
Level 2 | Fair Value, Recurring | Commercial paper
Cash and cash equivalents:
Amortized Cost	9,675
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Estimated Fair Value	9,675
Level 2 | Fair Value, Recurring | U.S. treasury securities
Short-term Investments:
Amortized Cost	277,357
Gross Unrealized Gains	6
Gross Unrealized Losses	(404)
Estimated Fair Value	276,959
Level 2 | Fair Value, Recurring | U.S. agency obligations
Short-term Investments:
Amortized Cost	73,465
Gross Unrealized Gains	0
Gross Unrealized Losses	(146)
Estimated Fair Value	73,319
Level 2 | Fair Value, Recurring | Corporate notes and bonds
Short-term Investments:
Amortized Cost	100,611
Gross Unrealized Gains	4
Gross Unrealized Losses	(355)
Estimated Fair Value	100,260
Level 2 | Fair Value, Recurring | Commercial paper
Short-term Investments:
Amortized Cost	43,758
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Estimated Fair Value	43,758
Level 2 | Fair Value, Recurring | Certificates of deposit
Short-term Investments:
Amortized Cost	31,529
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Estimated Fair Value	$ 31,529

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Details)	Oct. 31, 2023 USD ($)
Fair Value Disclosures [Abstract]
Total unrealized losses	$ (900,000)
Fair value measurement, transfers level 1 to level 2	$ 0

Derivative Instruments and He_3

Derivative Instruments and Hedging - Additional Information (Details) $ in Thousands	Oct. 31, 2023 USD ($)
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Accumulated other comprehensive loss related to foreign currency forwards	$ (300)
Foreign Exchange Forward
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount	$ 6,000

Derivative Instruments and He_4

Derivative Instruments and Hedging - Summary of the Fair Value of Derivative Instruments (Details) $ in Thousands	Oct. 31, 2023 USD ($)
Derivative Liabilities:
Total derivative liabilities	$ 321
Foreign Exchange Forward | Designated as Hedging Instrument
Derivative Liabilities:
Total derivative liabilities	$ 321

Derivative Instruments and He_5

Derivative Instruments and Hedging - Schedule of Derivatives and the Impact on AOCI (Details) $ in Thousands	9 Months Ended
	Oct. 31, 2023 USD ($)
Derivative Instruments and Hedging Activities [Roll Forward]
Beginning balance	$ 1,205,350
Ending balance	1,191,723
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent
Derivative Instruments and Hedging Activities [Roll Forward]
Beginning balance	0
Net gains (losses) recognized in other comprehensive income	(483)
Net (gains) losses reclassified from AOCI to earnings	162
Ending balance	$ (321)

Balance Sheet Components - Summ

Balance Sheet Components - Summary of Other Assets Non-current (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Supplemental Balance Sheet Disclosures [Abstract]
Property and equipment, net	$ 31,973	$ 24,594
Operating lease right-of-use assets	10,338	12,560
Other	1,108	902
Total other assets, non-current	$ 43,419	$ 38,056

Balance Sheet Components - Su_2

Balance Sheet Components - Summary of Property and Equipment Net (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Property Plant And Equipment [Line Items]
Total property and equipment	$ 45,586	$ 32,875
Less: accumulated depreciation and amortization	(13,613)	(8,281)
Property and equipment, net	$ 31,973	24,594
Furniture and fixtures
Property Plant And Equipment [Line Items]
Estimated Useful life	5 years
Total property and equipment	$ 1,329	1,292
Computers, equipment and software
Property Plant And Equipment [Line Items]
Estimated Useful life	3 years
Total property and equipment	$ 580	581
Capitalized internal-use software development costs
Property Plant And Equipment [Line Items]
Estimated Useful life	5 years
Total property and equipment	$ 38,038	25,817
Leasehold improvements
Property Plant And Equipment [Line Items]
Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]	Useful Life, Shorter of Lease Term or Asset Utility [Member]
Total property and equipment	$ 5,563	5,138
Construction in progress
Property Plant And Equipment [Line Items]
Total property and equipment	$ 76	$ 47

Balance Sheet Components - Addi

Balance Sheet Components - Additional Information (Details) - USD ($)	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Supplemental Balance Sheet Disclosures [Line Items]
Depreciation and amortization expense	$ (2,000,000)	$ (1,200,000)	$ (5,400,000)	$ (3,100,000)
Software capitalized costs	4,100,000	3,900,000	12,200,000	9,200,000
Amortization of capitalized costs	(1,700,000)	(900,000)	(4,500,000)	(2,300,000)
Impairment losses for deferred contract acquisition costs	$ 0	$ 0	$ 0	$ 0

Balance Sheet Components - Su_3

Balance Sheet Components - Summary of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Payables and Accruals [Abstract]
Operating lease liabilities	$ 3,683	$ 3,380
Acquisition holdback, current	3,554	0
Accrued expenses	3,262	4,222
Sales tax payable	1,470	1,480
Accrued income taxes payable	920	1,081
Derivative liabilities	321	0
Total accrued expenses and other current liabilities	$ 13,210	$ 10,163

Balance Sheet Components - Accr

Balance Sheet Components - Accrued Compensation and Benefits (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Compensation And Benefits [Abstract]
Accrued commissions	$ 10,113	$ 16,932
Accrued vacation	22,078	20,614
Accrued payroll and withholding taxes	5,679	11,574
ESPP employee contributions	7,992	4,247
Accrued bonus	3,342	3,220
Other	2,769	2,041
Total accrued compensation and benefits	$ 51,974	$ 58,628

Balance Sheet Components - Su_4

Balance Sheet Components - Summary of Activity of Deferred Contract Acquisition Costs (Details) - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022
Capitalized Contract Cost, Net, Classified [Roll Forward]
Beginning balance	$ 124,098	$ 89,331
Capitalization of contract acquisition costs	41,272	53,002
Amortization of deferred contract acquisition costs	(40,186)	(31,511)
Ending balance	125,184	110,822
Deferred contract acquisition costs, current	45,508	37,317
Deferred contract acquisition costs, non-current	79,676	73,505
Total deferred contract acquisition costs	$ 125,184	$ 110,822

Balance Sheet Components - Sche

Balance Sheet Components - Schedule of Other Liabilities, Non-current (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Supplemental Balance Sheet Disclosures [Abstract]
Operating lease liabilities, non-current	$ 9,301	$ 12,093
Acquisition holdback, non-current	546	0
Accrued commissions	1,029	713
Other liabilities, non-current	$ 10,876	$ 12,806

Leases - Schedule of Lease Cost

Leases - Schedule of Lease Costs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Leases [Abstract]
Short-term lease costs	$ 174	$ 39	$ 514	$ 184
Operating lease costs	878	878	2,634	2,634
Total lease costs	$ 1,052	$ 917	$ 3,148	$ 2,818

Leases - Summary of Lease Term

Leases - Summary of Lease Term and Discount Rate (Details)	Oct. 31, 2023
Leases [Abstract]
Weighted average remaining lease terms (in years)	3 years 4 months 24 days
Weighted average discount rate	3.80%

Leases - Schedule of Future Lea

Leases - Schedule of Future Lease Payments (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Leases [Abstract]
2024 (remaining three months)	$ 1,012
2025	4,150
2026	3,734
2027	3,737
2028	1,277
Total minimum lease payments	13,910
Less imputed interest	(926)
Present value of future minimum lease payments	12,984
Less current lease liabilities	(3,683)	$ (3,380)
Operating lease liabilities, non-current	$ 9,301	$ 12,093

Leases - Additional Information

Leases - Additional Information (Details) - USD ($)	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Leases [Abstract]
Operating right-of-use asset impairment losses	$ 0	$ 0	$ 0	$ 0

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Millions	Oct. 31, 2023	Jan. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Letters of credit outstanding amount	$ 1.8	$ 1.8

Common Stock and Stockholders_3

Common Stock and Stockholders' Equity - Schedule of Reserved Shares of Common Stock for Future Issuance (Details) - shares shares in Thousands	Oct. 31, 2023	Jan. 31, 2023
Class Of Stock [Line Items]
Common stock capital shares reserved for future issuance	51,214	45,377
2021 Equity Incentive Plan
Class Of Stock [Line Items]
Remaining shares available for future issuance	25,231	21,466
2021 Employee Stock Purchase Plan ("ESPP")
Class Of Stock [Line Items]
Common stock capital shares reserved for future issuance	4,481	3,008
Options outstanding
Class Of Stock [Line Items]
Common stock capital shares reserved for future issuance	8,011	9,315
Restricted stock units outstanding
Class Of Stock [Line Items]
Common stock capital shares reserved for future issuance	13,491	11,588

Common Stock and Stockholders_4

Common Stock and Stockholders' Equity - Schedule of Stock Option Activity (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	9 Months Ended		12 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Jan. 31, 2023
Aggregate Intrinsic Value
Aggregate intrinsic value, exercised	$ 33,900	$ 74,100
2021 Equity Incentive Plan
Number of Options Outstanding
Beginning balance (in shares)	9,315
Stock options exercised (in shares)	(1,286)
Stock options cancelled/forfeited/expired (in shares)	(18)
Ending balance (in shares)	8,011		9,315
Number of options outstanding, exercisable (in shares)	7,984
Weighted-Average Grant Date Fair Value
Beginning balance (in dollars per share)	$ 1.92
Stock options exercised (in dollars per share)	2.29
Stock options cancelled/forfeited/expired (in dollars per share)	22.39
Ending balance (in dollars per share)	1.82		$ 1.92
Weighted-average exercise price per share, exercisable (in dollars per share)	$ 1.75
Weighted- Average Remaining Contractual Term (in Years)	3 years 9 months 18 days		4 years 7 months 6 days
Weighted Average Remaining Contractual Term, Exercisable (in years)	3 years 9 months 18 days
Aggregate Intrinsic Value
Aggregate intrinsic value	$ 143,570		$ 281,837
Aggregate intrinsic value, exercised	33,922
Aggregate intrinsic value, exercisable	$ 143,442

Common Stock and Stockholders_5

Common Stock and Stockholders' Equity - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022	Jan. 31, 2023
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total grant-date fair value of stock options vested			$ 1,000	$ 3,800
Total intrinsic value of options exercised			33,900	74,100
Stock-based compensation expense, net of amounts capitalized	$ 43,766	$ 46,710	130,048	135,372
Unrecognized stock-based compensation expense	300	2,100	$ 300	$ 2,100
Unrecognized stock-based compensation expense, weighted-average period			1 year	1 year 3 months 18 days
ESPP employee payroll contributions	51,974		$ 51,974		$ 58,628
2021 Employee Stock Purchase Plan ("ESPP")
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation expense, net of amounts capitalized			9,600	$ 9,100
Unrecognized stock-based compensation expense	12,200		$ 12,200
Unrecognized stock-based compensation expense, weighted-average period			1 year 1 month 6 days
ESPP employee payroll contributions	$ 8,000		$ 8,000
2021 Employee Stock Purchase Plan ("ESPP") | Common Class A
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares available for sale	4,480,939		4,480,939
Restricted Stock Units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Grant-date fair value of vested shares			$ 134,000	105,100
Unrecognized stock-based compensation expense	$ 376,400	$ 389,100	$ 376,400	$ 389,100
Unrecognized stock-based compensation expense, weighted-average period			2 years 10 months 24 days	2 years 10 months 24 days

Common Stock and Stockholders_6

Common Stock and Stockholders' Equity - Schedule of Restricted Stock Units ("RSUs") Activity (Details) - 2021 Equity Incentive Plan - Restricted Stock Units shares in Thousands	9 Months Ended
	Oct. 31, 2023 $ / shares shares
Number of Awards
Beginning balance (in shares) | shares	11,588
RSUs granted (in shares) | shares	7,679
RSUs released (in shares) | shares	(3,855)
RSUs cancelled (in shares) | shares	(1,921)
Ending balance (in shares) | shares	13,491
Weighted-Average Grant Date Fair Value
Beginning balance (in dollars per share) | $ / shares	$ 42.48
RSUs granted (in dollars per share) | $ / shares	28.92
RSUs released (in dollars per share) | $ / shares	34.77
RSUs cancelled (in dollars per share) | $ / shares	37.53
Ending balance (in dollars per share) | $ / shares	$ 37.66

Common Stock and Stockholders_7

Common Stock and Stockholders' Equity - Summary of Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Stock-based compensation expense:
Stock-based compensation expense, net of amounts capitalized	$ 43,766	$ 46,710	$ 130,048	$ 135,372
Capitalized stock-based compensation	1,230	1,254	3,685	3,042
Total stock-based compensation expense	44,996	47,964	133,733	138,414
Cost of revenue | Support
Stock-based compensation expense:
Stock-based compensation expense, net of amounts capitalized	2,411	2,152	7,511	6,332
Cost of revenue | Cloud-hosted services
Stock-based compensation expense:
Stock-based compensation expense, net of amounts capitalized	601	792	1,767	2,118
Cost of revenue | Professional services and other
Stock-based compensation expense:
Stock-based compensation expense, net of amounts capitalized	734	722	1,947	2,102
Sales and marketing
Stock-based compensation expense:
Stock-based compensation expense, net of amounts capitalized	13,923	15,398	41,365	44,212
Research and development
Stock-based compensation expense:
Stock-based compensation expense, net of amounts capitalized	12,674	14,988	37,347	40,233
General and administrative
Stock-based compensation expense:
Stock-based compensation expense, net of amounts capitalized	$ 13,423	$ 12,658	$ 40,111	$ 40,375

Net Loss Per Share Attributab_3

Net Loss Per Share Attributable to Common Stockholders - Additional Information (Details)	9 Months Ended
	Oct. 31, 2023 vote
Class A Common Stock
Class Of Stock [Line Items]
Common stock, voting rights	1
Class B Common Stock
Class Of Stock [Line Items]
Common stock, voting rights	10

Net Loss Per Share Attributab_4

Net Loss Per Share Attributable to Common Stockholders - Summary of Computation of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended						9 Months Ended
	Oct. 31, 2023	Jul. 31, 2023	Apr. 30, 2023	Oct. 31, 2022	Jul. 31, 2022	Apr. 30, 2022	Oct. 31, 2023	Oct. 31, 2022
Numerator:
Net loss	$ (39,473)	$ (66,315)	$ (53,258)	$ (71,958)	$ (74,764)	$ (78,217)	$ (159,046)	$ (224,939)
Denominator:
Weighted-average shares used to compute net loss per share attributable to Class A and Class B common stockholders, basic (in shares)	194,600			187,080			192,693	185,124
Weighted-average shares used to compute net loss per share attributable to Class A and Class B common stockholders, diluted (in shares)	194,600			187,080			192,693	185,124
Net loss per share attributable to Class A and Class B common stockholders, basic (in dollars per share)	$ (0.20)			$ (0.38)			$ (0.83)	$ (1.22)
Net loss per share attributable to Class A and Class B common stockholders, diluted (in dollars per share)	$ (0.20)			$ (0.38)			$ (0.83)	$ (1.22)

Net Loss Per Share Attributab_5

Net Loss Per Share Attributable to Common Stockholders - Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss Per Share (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share	22,707	23,724	22,579	23,472
Outstanding stock options and restricted stock units
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share	21,502	22,233	21,502	22,233
Share purchase rights under the ESPP
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share	1,205	1,491	1,077	1,239

Reduction in Workforce and Re_2

Reduction in Workforce and Related Charges - Additional Information (Details) $ in Millions		9 Months Ended
	Jun. 07, 2023	Oct. 31, 2023 USD ($)
Restructuring Cost and Reserve [Line Items]
Workforce reduction percentage	0.08
Restructuring charges		$ 7.3
Benefit in stock-based compensation expense		2.1
Sales and marketing
Restructuring Cost and Reserve [Line Items]
Restructuring charges		4.4
Research and development
Restructuring Cost and Reserve [Line Items]
Restructuring charges		1.7
General and administrative
Restructuring Cost and Reserve [Line Items]
Restructuring charges		0.6
Cost of Sales
Restructuring Cost and Reserve [Line Items]
Restructuring charges		0.6
Employee Severance
Restructuring Cost and Reserve [Line Items]
Restructuring charges		6.1
Payroll Taxes
Restructuring Cost and Reserve [Line Items]
Restructuring charges		0.3
Other Restructuring
Restructuring Cost and Reserve [Line Items]
Restructuring charges		$ 0.9

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Income Tax Contingency [Line Items]
Provision for income taxes	$ 258	$ 322	$ 480	$ 744
Partial release of valuation allowance			$ 500